Selected research
Industry Research
Gene Mutagenesis Service Industry Research Report 2026
Market perspective
The global Gene Mutagenesis Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Gene Mutagenesis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Gene Mutagenesis Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Gene Mutagenesis Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Gene Mutagenesis Service include Thermofisher, Azenta Life Sciences, Creative Biogene, Charles River, ACGT, Vectorbuilder, Creative Biolabs, Bio Basic and Applied Biological Materials, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Gene Mutagenesis Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Gene Mutagenesis Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gene Mutagenesis Service Market by Company
Thermofisher
Azenta Life Sciences
Creative Biogene
Charles River
ACGT
Vectorbuilder
Creative Biolabs
Bio Basic
Applied Biological Materials
NovoPro Bioscience
Abace-Biology
Sangon Biotech
Genscript
Beijing Tsingke Biotech
Gene Mutagenesis Service Segment by Type
Site-Directed Mutagenesis
Random Mutagenesis
Gene Mutagenesis Service Segment by Application
Pharmaceutical Industry
Research
Others
Gene Mutagenesis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Mutagenesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Mutagenesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Mutagenesis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Gene Mutagenesis Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Site-Directed Mutagenesis
- Random Mutagenesis
Applications
- Pharmaceutical Industry
- Research
- Others
Companies covered
- Thermofisher
- Azenta Life Sciences
- Creative Biogene
- Charles River
- ACGT
- Vectorbuilder
- Creative Biolabs
- Bio Basic
- Applied Biological Materials
- NovoPro Bioscience
- Abace-Biology
- Sangon Biotech
- Genscript
- Beijing Tsingke Biotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Gene Mutagenesis Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Site-Directed Mutagenesis
- 2.2.3 Random Mutagenesis
- 2.3 Gene Mutagenesis Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Industry
- 2.3.3 Research
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Gene Mutagenesis Service Breakdown Data by Type
- 3.1 Global Gene Mutagenesis Service Historic Market Size by Type (2021-2026)
- 3.2 Global Gene Mutagenesis Service Forecasted Market Size by Type (2027-2032)
4 Gene Mutagenesis Service Breakdown Data by Application
- 4.1 Global Gene Mutagenesis Service Historic Market Size by Application (2021-2026)
- 4.2 Global Gene Mutagenesis Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Gene Mutagenesis Service Market Perspective (2021-2032)
- 5.2 Global Gene Mutagenesis Service Growth Trends by Region
- 5.2.1 Global Gene Mutagenesis Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Gene Mutagenesis Service Historic Market Size by Region (2021-2026)
- 5.2.3 Gene Mutagenesis Service Forecasted Market Size by Region (2027-2032)
- 5.3 Gene Mutagenesis Service Market Dynamics
- 5.3.1 Gene Mutagenesis Service Industry Trends
- 5.3.2 Gene Mutagenesis Service Market Drivers
- 5.3.3 Gene Mutagenesis Service Market Challenges
- 5.3.4 Gene Mutagenesis Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Gene Mutagenesis Service Players by Revenue
- 6.1.1 Global Top Gene Mutagenesis Service Players by Revenue (2021-2026)
- 6.1.2 Global Gene Mutagenesis Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Gene Mutagenesis Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Gene Mutagenesis Service Head Office and Area Served
- 6.4 Global Gene Mutagenesis Service Players, Product Type & Application
- 6.5 Global Gene Mutagenesis Service Manufacturers Established Date
- 6.6 Global Gene Mutagenesis Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Gene Mutagenesis Service Market Size (2021-2032)
- 7.2 North America Gene Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Gene Mutagenesis Service Market Size by Country (2021-2026)
- 7.4 North America Gene Mutagenesis Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Gene Mutagenesis Service Market Size (2021-2032)
- 8.2 Europe Gene Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Gene Mutagenesis Service Market Size by Country (2021-2026)
- 8.4 Europe Gene Mutagenesis Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Gene Mutagenesis Service Market Size (2021-2032)
- 9.2 Asia-Pacific Gene Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Gene Mutagenesis Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Gene Mutagenesis Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Gene Mutagenesis Service Market Size (2021-2032)
- 10.2 South America Gene Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Gene Mutagenesis Service Market Size by Country (2021-2026)
- 10.4 South America Gene Mutagenesis Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Gene Mutagenesis Service Market Size (2021-2032)
- 11.2 Middle East & Africa Gene Mutagenesis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Gene Mutagenesis Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Gene Mutagenesis Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermofisher
- 12.1.1 Thermofisher Company Information
- 12.1.2 Thermofisher Business Overview
- 12.1.3 Thermofisher Revenue in Gene Mutagenesis Service Business (2021-2026)
- 12.1.4 Thermofisher Gene Mutagenesis Service Product Portfolio
- 12.1.5 Thermofisher Recent Developments
- 12.2 Azenta Life Sciences
- 12.2.1 Azenta Life Sciences Company Information
- 12.2.2 Azenta Life Sciences Business Overview
- 12.2.3 Azenta Life Sciences Revenue in Gene Mutagenesis Service Business (2021-2026)
- 12.2.4 Azenta Life Sciences Gene Mutagenesis Service Product Portfolio
- 12.2.5 Azenta Life Sciences Recent Developments
- 12.3 Creative Biogene
- 12.3.1 Creative Biogene Company Information
- 12.3.2 Creative Biogene Business Overview
- 12.3.3 Creative Biogene Revenue in Gene Mutagenesis Service Business (2021-2026)
- 12.3.4 Creative Biogene Gene Mutagenesis Service Product Portfolio
- 12.3.5 Creative Biogene Recent Developments
- 12.4 Charles River
- 12.4.1 Charles River Company Information
- 12.4.2 Charles River Business Overview
- 12.4.3 Charles River Revenue in Gene Mutagenesis Service Business (2021-2026)
- 12.4.4 Charles River Gene Mutagenesis Service Product Portfolio
- 12.4.5 Charles River Recent Developments
- 12.5 ACGT
- 12.5.1 ACGT Company Information
- 12.5.2 ACGT Business Overview
- 12.5.3 ACGT Revenue in Gene Mutagenesis Service Business (2021-2026)
- 12.5.4 ACGT Gene Mutagenesis Service Product Portfolio
- 12.5.5 ACGT Recent Developments
- 12.6 Vectorbuilder
- 12.6.1 Vectorbuilder Company Information
- 12.6.2 Vectorbuilder Business Overview
- 12.6.3 Vectorbuilder Revenue in Gene Mutagenesis Service Business (2021-2026)
- 12.6.4 Vectorbuilder Gene Mutagenesis Service Product Portfolio
- 12.6.5 Vectorbuilder Recent Developments
- 12.7 Creative Biolabs
- 12.7.1 Creative Biolabs Company Information
- 12.7.2 Creative Biolabs Business Overview
- 12.7.3 Creative Biolabs Revenue in Gene Mutagenesis Service Business (2021-2026)
- 12.7.4 Creative Biolabs Gene Mutagenesis Service Product Portfolio
- 12.7.5 Creative Biolabs Recent Developments
- 12.8 Bio Basic
- 12.8.1 Bio Basic Company Information
- 12.8.2 Bio Basic Business Overview
- 12.8.3 Bio Basic Revenue in Gene Mutagenesis Service Business (2021-2026)
- 12.8.4 Bio Basic Gene Mutagenesis Service Product Portfolio
- 12.8.5 Bio Basic Recent Developments
- 12.9 Applied Biological Materials
- 12.9.1 Applied Biological Materials Company Information
- 12.9.2 Applied Biological Materials Business Overview
- 12.9.3 Applied Biological Materials Revenue in Gene Mutagenesis Service Business (2021-2026)
- 12.9.4 Applied Biological Materials Gene Mutagenesis Service Product Portfolio
- 12.9.5 Applied Biological Materials Recent Developments
- 12.10 NovoPro Bioscience
- 12.10.1 NovoPro Bioscience Company Information
- 12.10.2 NovoPro Bioscience Business Overview
- 12.10.3 NovoPro Bioscience Revenue in Gene Mutagenesis Service Business (2021-2026)
- 12.10.4 NovoPro Bioscience Gene Mutagenesis Service Product Portfolio
- 12.10.5 NovoPro Bioscience Recent Developments
- 12.11 Abace-Biology
- 12.11.1 Abace-Biology Company Information
- 12.11.2 Abace-Biology Business Overview
- 12.11.3 Abace-Biology Revenue in Gene Mutagenesis Service Business (2021-2026)
- 12.11.4 Abace-Biology Gene Mutagenesis Service Product Portfolio
- 12.11.5 Abace-Biology Recent Developments
- 12.12 Sangon Biotech
- 12.12.1 Sangon Biotech Company Information
- 12.12.2 Sangon Biotech Business Overview
- 12.12.3 Sangon Biotech Revenue in Gene Mutagenesis Service Business (2021-2026)
- 12.12.4 Sangon Biotech Gene Mutagenesis Service Product Portfolio
- 12.12.5 Sangon Biotech Recent Developments
- 12.13 Genscript
- 12.13.1 Genscript Company Information
- 12.13.2 Genscript Business Overview
- 12.13.3 Genscript Revenue in Gene Mutagenesis Service Business (2021-2026)
- 12.13.4 Genscript Gene Mutagenesis Service Product Portfolio
- 12.13.5 Genscript Recent Developments
- 12.14 Beijing Tsingke Biotech
- 12.14.1 Beijing Tsingke Biotech Company Information
- 12.14.2 Beijing Tsingke Biotech Business Overview
- 12.14.3 Beijing Tsingke Biotech Revenue in Gene Mutagenesis Service Business (2021-2026)
- 12.14.4 Beijing Tsingke Biotech Gene Mutagenesis Service Product Portfolio
- 12.14.5 Beijing Tsingke Biotech Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst